Çinier,G.Hayıroğlu,M.İ.Çınar,T.Pay,L.Yumurtaş,A.Ç.Tezen,O.Gürkan,K.2024-05-252024-05-25202210019-483210.1016/j.ihj.2022.01.0032-s2.0-85124194557https://doi.org/10.1016/j.ihj.2022.01.003https://hdl.handle.net/20.500.14517/1669Implantable cardioverter defibrillators (ICD) are recommended in heart failure with reduced ejection fraction (HFrEF) patients to reduce arrhythmic deaths. This study aimed to identify risk factors associated with mortality within one-year following the ICD. The data from our hospital's electronic database system was extracted for patients who were implanted ICD secondary to HFrEF between 2009 and 2019. Overall, 1107 patients were included in the present analysis. Mortality rate at one-year following the device implantation was 4.7%. In multivariate analysis; age, atrial fibrillation, New York Heart Association classification >2, blood urea nitrogen, pro-brain natriuretic peptide and albumin independently predicted one year mortality. © 2022 Cardiological Society of Indiaeninfo:eu-repo/semantics/openAccessEarly mortalityHeart failure with reduced ejection fractionImplantable cardiac defibrillatorArticleQ3742127130PubMed:35104458